Showing results (131-140 of 251) with videos related to
Sort By:
Pageof 26
Cancer Medicine|January 9, 2023
Phase 1 study of DS-1205c combined with gefitinib for EGFR mutation-positive non-small cell lung cancerKoichi Goto, Yoshimasa Shiraishi, Haruyasu Murakami, et al.Lung Cancer (Amsterdam, Netherlands)|May 17, 2011
Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failureTakehito Shukuya, Toshiaki Takahashi, Tateaki Naito, et al.Anticancer Research|January 31, 2012
Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancerTakehito Shukuya, Toshiaki Takahashi, Hideyuki Harada, et al.Annals of Thoracic Medicine|January 17, 2015
Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancerHisao Imai, Keita Mori, Kazushige Wakuda, et al.Cancer Chemotherapy and Pharmacology|January 22, 2013
Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lungHidemi Kiyota, Isamu Okamoto, Masayuki Takeda, et al.Asia-Pacific Journal of Oncology Nursing|March 19, 2025
Correlation between cancer cachexia and psychosocial impact in older patients with advanced lung cancer undergoing chemotherapyRika Sato, Tateaki Naito, Haruyasu Murakami, et al.Thoracic Cancer|June 20, 2024
Suitability of frozen cell pellets from cytology specimens for the Amoy 9-in-1 assay in patients with non-small cell lung cancerHiroaki Kodama, Haruyasu Murakami, Nobuaki Mamesaya, et al.Lung Cancer (Amsterdam, Netherlands)|February 4, 2012
Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancerAkira Ono, Tateaki Naito, Ichiro Ito, et al.American Journal of Translational Research|November 3, 2011
LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancerKyoichi Kaira, Noboru Oriuchi, Toshiaki Takahashi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumorsTomohide Tamura, Hironobu Minami, Yasuhide Yamada, et al.Pageof 26